Wordt geladen...

Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)

Recently, the standard of care for metastatic Castration Resistant Prostate Cancer (mCRPC) has changed considerably. Persistent androgen receptor (AR) signaling has been identified as a target for novel therapies and reengages the fact that AR continues to be the primary target responsible for metas...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gupta, Eva, Guthrie, Troy, Tan, Winston
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167156/
https://ncbi.nlm.nih.gov/pubmed/25062956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-14-55
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!